Fecal Protease Activity Is Associated with Compositional Alterations in the Intestinal Microbiota

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Carroll, Ian M ^a   Ringel Kulka, Tamar ^b   Ferrier, Laurent ^c   Wu, Michael C ^b   Siddle, Jennica P ^a   Bueno, Lionel ^c   Ringel, Yehuda ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FECAL PROTEINASE; INTESTINE ENZYME; PROTEINASE; RNA 16S; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COMMUNITY STRUCTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORIOBACTERIALES; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ISOLATION; FECES ANALYSIS; FEMALE; HIGH THROUGHPUT SEQUENCING; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACHNOSPIRACEAE; LACTOBACILLALES; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; POPULATION RESEARCH; PROTEIN INTERACTION; RNA GENE; RUMINOCOCCACEAE; STREPTOCOCCACEAE;

ADULT; DNA, BACTERIAL; FECES; FEMALE; HUMANS; INTESTINES; LACTOBACILLALES; MALE; PEPTIDE HYDROLASES; RNA, RIBOSOMAL, 16S; STREPTOCOCCACEAE;

EID: 84885774174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078017     Document Type: Article

References (44)

1. Antalis TM, Shea-Donohue T, Vogel SN, Sears C, Fasano A, (2007) Mechanisms of disease: protease functions in intestinal mucosal pathobiology. Nat Clin Pract Gastroenterol Hepatol 4: 393-402. doi:10.1038/ncpgasthep0846. PubMed: 17607295.
2. Macfarlane RG, (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202: 498-499. doi:10.1038/202498a0. PubMed: 14167839.
3. Turk B, (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 5: 785-799. doi:10.1038/nrd2092. PubMed: 16955069.
4. Gibson SA, McFarlan C, Hay S, MacFarlane GT, (1989) Significance of microflora in proteolysis in the colon. Appl Environ Microbiol 55: 679-683. PubMed: 2648991.
5. Macfarlane GT, Allison C, Gibson SA, Cummings JH, (1988) Contribution of the microflora to proteolysis in the human large intestine. J Appl Bacteriol 64: 37-46. doi:10.1111/j.1365-2672.1988.tb02427.x. PubMed: 3127369.
6. Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, et al. (2007) A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 5: 550-555. doi:10.1016/j.cgh.2006.12.004. PubMed: 17336590.
7. Róka R, Demaude J, Cenac N, Ferrier L, Salvador-Cartier C, et al. (2007) Colonic luminal proteases activate colonocyte proteinase-activated receptor-2 and regulate paracellular permeability in mice. Neurogastroenterol Motil 19: 57-65. doi:10.1111/j.1365-2982.2006.00851.x. PubMed: 17187589.
8. Pruteanu M, Hyland NP, Clarke DJ, Kiely B, Shanahan F, (2011) Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory bowel diseases. Inflamm Bowel Dis 17: 1189-1200. doi:10.1002/ibd.21475. PubMed: 20853433.
9. Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, et al. (2006) Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 101: 1288-1294. doi:10.1111/j.1572-0241.2006.00672.x. PubMed: 16771951.
10. Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, et al. (2008) Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 57: 591-599. doi:10.1136/gut.2007.140210. PubMed: 18194983.
11. Shulman RJ, Eakin MN, Czyzewski DI, Jarrett M, Ou CN, (2008) Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 153: 646-650. doi:10.1016/j.jpeds.2008.04.062. PubMed: 18538790.
12. Bustos D, Negri G, De Paula JA, Di Carlo M, Yapur V, et al. (1998) Colonic proteinases: increased activity in patients with ulcerative colitis. Medicina (B Aires) 58: 262-264.
13. Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, et al. (2007) Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117: 636-647. doi:10.1172/JCI29255. PubMed: 17304351.
14. Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, et al. (2009) Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain 144: 209-217. doi:10.1016/j.pain.2009.04.017. PubMed: 19450926.
15. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y, (2012) Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 24: 521-530, e248 doi:10.1111/j.1365-2982.2012.01891.x. PubMed: 22339879.
16. Carroll IM, Ringel-Kulka T, Siddle JP, Klaenhammer TR, Ringel Y, (2012) Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLOS ONE 7: e46953. doi:10.1371/journal.pone.0046953. PubMed: 23071673.
17. Williams DA, Reed SD, (1990) Comparison of methods for assay of fecal proteolytic activity. Vet Clin Pathol 19: 20-24. doi:10.1111/j.1939-165X.1990.tb00536.x. PubMed: 12684942.
18. Schloss PD, (2010) The effects of alignment quality, distance calculation method, sequence filtering, and region on the analysis of 16S rRNA gene-based studies. PLOS Comput Biol 6: e1000844. PubMed: 20628621.
19. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, et al. (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335-336. doi:10.1038/nmeth.f.303. PubMed: 20383131.
20. McDonald D, Price MN, Goodrich J, Nawrocki EP, Desantis TZ, et al. (2012) An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. Isme J 6: 610-618. doi:10.1038/ismej.2011.139. PubMed: 22134646.
21. Lozupone C, Knight R, (2005) UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71: 8228-8235. doi:10.1128/AEM.71.12.8228-8235.2005. PubMed: 16332807.
22. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R, (2011) UniFrac: an effective distance metric for microbial community comparison. Isme J 5: 169-172. doi:10.1038/ismej.2010.133. PubMed: 20827291.
23. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284. doi:10.1016/S0166-4328(01)00297-2. PubMed: 11682119.
24. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736. doi:10.1073/pnas.0804812105. PubMed: 18936492.
25. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189. doi:10.1002/ibd.20903. PubMed: 19235886.
26. Midtvedt T, Zabarovsky E, Norin E, Bark J, Gizatullin R, et al. (2013) Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform. PLOS ONE 8: e66074. doi:10.1371/journal.pone.0066074. PubMed: 23840402.
27. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780-13785. doi:10.1073/pnas.0706625104. PubMed: 17699621.
28. Bonifait L, Grenier D, (2011) The SspA subtilisin-like protease of Streptococcus suis triggers a pro-inflammatory response in macrophages through a non-proteolytic mechanism. BMC Microbiol 11: 47. doi:10.1186/1471-2180-11-47. PubMed: 21362190.
29. Einsfeldt K, Severo Júnior JB, Corrêa Argondizzo AP, Medeiros MA, Alves TL, et al. (2011) Cloning and expression of protease ClpP from Streptococcus pneumoniae in Escherichia coli: study of the influence of kanamycin and IPTG concentration on cell growth, recombinant protein production and plasmid stability. Vaccine 29: 7136-7143. doi:10.1016/j.vaccine.2011.05.073. PubMed: 21651937.
30. Mirza S, Wilson L, Benjamin WH Jr., Novak J, Barnes S, et al. (2011) Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin. Infect Immun 79: 2440-2450. doi:10.1128/IAI.00489-10. PubMed: 21422179.
31. Tsui HC, Keen SK, Sham LT, Wayne KJ, Winkler ME, (2011) Dynamic distribution of the SecA and SecY translocase subunits and septal localization of the HtrA surface chaperone/protease during Streptococcus pneumoniae D39 cell division. mBio 2([MedlinePgn:]) PubMed: 21990615.
32. Wani JH, Gilbert JV, Plaut AG, Weiser JN, (1996) Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun 64: 3967-3974. PubMed: 8926056.
33. Connolly KL, Roberts AL, Holder RC, Reid SD, (2011) Dispersal of Group A streptococcal biofilms by the cysteine protease SpeB leads to increased disease severity in a murine model. PLOS ONE 6: e18984. doi:10.1371/journal.pone.0018984. PubMed: 21547075.
34. Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S, (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70: 6113-6122. doi:10.1128/AEM.70.10.6113-6122.2004. PubMed: 15466557.
35. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, et al. (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133: 24-33. doi:10.1053/j.gastro.2007.04.005. PubMed: 17631127.
36. Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, et al. (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141: 1782-1791. doi:10.1053/j.gastro.2011.06.072. PubMed: 21741921.
37. Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, et al. (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141: 1792-1801. doi:10.1053/j.gastro.2011.07.043. PubMed: 21820992.
38. Eeckhaut V, Van Immerseel F, Teirlynck E, Pasmans F, Fievez V, et al. (2008) Butyricicoccus pullicaecorum gen. nov., sp. nov., an anaerobic, butyrate-producing bacterium isolated from the caecal content of a broiler chicken. Int J Syst Evol Microbiol 58: 2799-2802. doi:10.1099/ijs.0.65730-0. PubMed: 19060061.
39. Hague A, Singh B, Paraskeva C, (1997) Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 112: 1036-1040. doi:10.1053/gast.1997.v112.agast971036. PubMed: 9041270.
40. Saifeddine M, Al-Ani B, Cheng CH, Wang L, Hollenberg MD, (1996) Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 118: 521-530. doi:10.1111/j.1476-5381.1996.tb15433.x. PubMed: 8762073.
41. Corvera CU, Déry O, McConalogue K, Böhm SK, Khitin LM, et al. (1997) Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Invest 100: 1383-1393. doi:10.1172/JCI119658. PubMed: 9294103.
42. Kanazawa M, Palsson OS, Thiwan SI, Turner MJ, van Tilburg MA, et al. (2008) Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol 103: 2550-2561. doi:10.1111/j.1572-0241.2008.02066.x. PubMed: 18684175.
43. Packey CD, Sartor RB, (2009) Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22: 292-301. doi:10.1097/QCO.0b013e32832a8a5d. PubMed: 19352175.
44. Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, et al. (1994) Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 35: 68-72. doi:10.1136/gut.35.1.68. PubMed: 8307453.